Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.

about

Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.

Item

http://www.wikidata.org/entity/Q36236545

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Spleen Tyrosine Kinase Is Invo ...... Chronic Lymphocytic Leukemia.

@ast

Spleen Tyrosine Kinase Is Invo ...... Chronic Lymphocytic Leukemia.

@en

type

Item

label

Spleen Tyrosine Kinase Is Invo ...... Chronic Lymphocytic Leukemia.

@ast

Spleen Tyrosine Kinase Is Invo ...... Chronic Lymphocytic Leukemia.

@en

prefLabel

Spleen Tyrosine Kinase Is Invo ...... Chronic Lymphocytic Leukemia.

@ast

Spleen Tyrosine Kinase Is Invo ...... Chronic Lymphocytic Leukemia.

@en

P1476

Spleen Tyrosine Kinase Is Invo ...... Chronic Lymphocytic Leukemia.

@en

P2093

Arlette Dörffel

http://www.w3.org/2001/XMLSchema#string

Christine Dierks

http://www.w3.org/2001/XMLSchema#string

Fabio Malavasi

http://www.w3.org/2001/XMLSchema#string

Hassan Jumaa

http://www.w3.org/2001/XMLSchema#string

Hendrik Veelken

http://www.w3.org/2001/XMLSchema#string

Justus Duyster

http://www.w3.org/2001/XMLSchema#string

Kathrin Kläsener

http://www.w3.org/2001/XMLSchema#string

Kerstin Leberecht

http://www.w3.org/2001/XMLSchema#string

Maike Buchner

http://www.w3.org/2001/XMLSchema#string

Marco Benkisser-Petersen

http://www.w3.org/2001/XMLSchema#string

P2860

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies

Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22

An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

Ratiometric analysis of fura red by flow cytometry: a technique for monitoring intracellular calcium flux in primary cell subsets

Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk

P304

e0169159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0169159

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Katja Zirlik

P577

2016-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28036404

http://www.w3.org/2001/XMLSchema#string

P932

5201248

http://www.w3.org/2001/XMLSchema#string